B
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K146.9 KBBetter Therapeutics, Inc.Mar 21, 4:01 PM ET·0001193125-24-073819
- 8-K152.5 KBBetter Therapeutics, Inc.Mar 15, 9:33 AM ET·0001193125-24-068672
- 8-K156.4 KBBetter Therapeutics, Inc.Mar 14, 9:35 AM ET·0001193125-24-067483
- 8-K18.3 MBBetter Therapeutics, Inc.Mar 11, 9:01 AM ET·0001193125-24-064404
- 8-K172.7 KBBetter Therapeutics, Inc.Mar 4, 8:51 AM ET·0001193125-24-056981
- SC 13G/A58.9 KBBetter Therapeutics, Inc.Feb 13, 1:00 PM ET·0001062993-24-002926
- SC 13D/A325.9 KBBetter Therapeutics, Inc.Feb 12, 4:28 PM ET·0001193125-24-032123
- S-1/A13.4 MBBetter Therapeutics, Inc.Feb 6, 9:02 AM ET·0001193125-24-024856
- SC 13D/A144.5 KBBetter Therapeutics, Inc.Jan 25, 4:30 PM ET·0001193125-24-015451
- 8-K389.3 KBBetter Therapeutics, Inc.Jan 8, 4:42 PM ET·0001193125-24-004495
Insiders
10- Appelbaum Kevin JDirector, Chief Executive Officer, 10% Owner
- Armanino Andrew J.Director
- Berman Mark A.Chief Medical Officer
- Carmona Richard HDirector
- Georgianna Maule-Ffinch 2015 Trust10% Owner
- Granger ElderDirector
- Haight NelsonDirector
- Heinen MarkSee Remarks
- KARBE FRANKDirector, See Remarks
- LAVIZZO-MOUREY RISA JDirector
Tickers
No tickers on record
Addresses
business
548 MARKET ST. #49404
SAN FRANCISCO, CA, 94101
mailing
548 MARKET ST. #49404
SAN FRANCISCO, CA, 94101
Former Names
- Mountain Crest Acquisition Corp II2021-10-28